NCT00263796View on ClinicalTrials.gov

An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

September 30, 2012

Conditions
Autism
Interventions
DRUG

Oxytocin

10 international units = 1 cc, IV over 4 hours

DRUG

Placebo

Normal Saline, IV over 4 hours

Trial Locations (1)

10029-6574

Mount Sinai School of Medicine, New York

All Listed Sponsors
lead

Anagnostou, Evdokia, M.D.

INDIV

NCT00263796 - An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism | Biotech Hunter | Biotech Hunter